Literature DB >> 23122392

Cardiac myxoma induced paraneoplastic syndromes: a review of the literature.

Marcus Smith1, Muhammad A Chaudhry, Pedro Lozano, Mary Beth Humphrey.   

Abstract

BACKGROUND: Atrial myxomas are the most common benign tumors of the heart and may present with a wide variety of symptoms. Although 45% of patients present with neurological symptoms, a diverse range of systemic symptoms also occur.
METHODS: A systemic review of the literature related to the diagnosis, treatment, pathogenesis, and symptoms associated with atrial myxomas was performed.
RESULTS: Here we summarize the current state of understanding about myxoma pathogenesis and treatments are described. We review the common and rare local and systemic effects of myxomas. Additionally, we review the paraneoplastic and metastatic potential of myxomas.
CONCLUSIONS: A better understanding of the diverse disease presentations, paraneoplastic syndromes, and side effects of cytokine abnormalities stemming from myxomas will aid the physician in earlier detection and monitoring of disease recurrence. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 23122392     DOI: 10.1016/j.ejim.2012.05.015

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

1.  Atrial myxoma: a rare but well-described cause of increased erythrocyte sedimentation rate and anaemia.

Authors:  Mattias Ekström; Peter Svenarud
Journal:  BMJ Case Rep       Date:  2015-05-12

2.  Risk factors for embolism in cardiac myxoma: a retrospective analysis.

Authors:  Deng-Ke He; Yu-Feng Zhang; Yin Liang; Shi-Xing Ye; Chong Wang; Bo Kang; Zhi-Nong Wang
Journal:  Med Sci Monit       Date:  2015-04-22

Review 3.  Unusual aspects of cardiac myxoma.

Authors:  Shi Min Yuan; Song Li Yan; Ning Wu
Journal:  Anatol J Cardiol       Date:  2017-03       Impact factor: 1.596

4.  Commentary: Cutaneous presentation of cardiac myxoma.

Authors:  Rebecca M Gerlach; Mark A Chaney
Journal:  JTCVS Tech       Date:  2020-01-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.